Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	86.06	144.76	82.25	124.78	208.89	304.96
Short-Term Investments	-	-	-	42.09	50.44	-
Cash & Short-Term Investments	86.06	144.76	82.25	166.86	259.33	304.96
Cash Growth	-54.54%	76.00%	-50.71%	-35.66%	-14.96%	51.89%
Receivables	107.75	80.14	48.49	33.73	22.93	12.39
Inventory	114.47	94.49	65.62	35.2	34.39	16.14
Prepaid Expenses	34.32	18.6	4.7	10.89	12.31	12.41
Total Current Assets	342.6	338	201.07	246.68	328.97	345.9
Property, Plant & Equipment	4.43	5.77	4.68	1.2	2.56	7.31
Other Intangible Assets	0.06	0.06	0.06	0.06	0.06	0.06
Other Long-Term Assets	-	-	-	-	50	-
Total Assets	347.09	343.82	205.8	247.94	381.59	353.26
Accounts Payable	74.7	51.65	31.72	23.04	17.56	51.98
Accrued Expenses	16.66	24.63	28.44	18.63	21.23	27.43
Current Portion of Long-Term Debt	121.08	102.16	34.83	24.76	11.3	5.39
Current Portion of Leases	2.74	2.74	1.55	0.38	1.39	2.59
Current Unearned Revenue	22.31	8.52	25.4	3.51	5.68	1.66
Other Current Liabilities	61.3	56.54	34.28	21.99	16.19	5.03
Total Current Liabilities	298.8	246.23	156.22	92.31	73.35	94.07
Long-Term Debt	473.05	483.74	501.55	478.74	504.02	350.58
Long-Term Leases	1.31	2.57	3.02	0.67	0.52	3.45
Long-Term Unearned Revenue	-	-	-	-	0.63	-
Other Long-Term Liabilities	7.44	-	-	-	-	1.29
Total Liabilities	780.59	732.54	660.79	571.72	578.53	449.39
Common Stock	0.2	0.2	0.12	0.08	0.06	0.03
Additional Paid-In Capital	1,275	1,267	1,149	1,071	964.4	797.66
Retained Earnings	-1,654	-1,601	-1,549	-1,340	-1,106	-838.82
Treasury Stock	-55	-55	-55	-55	-55	-55
Comprehensive Income & Other	-	-	-	-0	-0.03	-
Shareholders' Equity	-433.51	-388.72	-454.99	-323.78	-196.94	-96.13
Total Liabilities & Equity	347.09	343.82	205.8	247.94	381.59	353.26
Total Debt	598.18	591.21	540.95	504.55	517.24	362.01
Net Cash (Debt)	-512.12	-446.45	-458.7	-337.69	-257.9	-57.05
Net Cash Per Share	-2.61	-2.39	-4.45	-5.09	-8.92	-2.08
Filing Date Shares Outstanding	201.62	197.85	185.05	76.57	62.82	27.94
Total Common Shares Outstanding	200.16	195.85	118.21	74.57	60.88	25.92
Working Capital	43.8	91.77	44.84	154.38	255.62	251.83
Book Value Per Share	-2.17	-1.98	-3.85	-4.34	-3.23	-3.71
Tangible Book Value	-433.57	-388.78	-455.05	-323.83	-197	-96.19
Tangible Book Value Per Share	-2.17	-1.99	-3.85	-4.34	-3.24	-3.71
Machinery	-	0.86	0.86	1.45	1.45	1.45
Leasehold Improvements	-	0.19	0.19	0.3	0.3	0.3

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q